Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06793371
PHASE2

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Sponsor: Cytokinetics

View on ClinicalTrials.gov

Summary

This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF.

Official title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-4021586 in Adults With Symptomatic Heart Failure With Preserved Ejection Fraction

Key Details

Gender

All

Age Range

40 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-02-06

Completion Date

2026-09

Last Updated

2026-01-12

Healthy Volunteers

No

Interventions

DRUG

CK-4021586 (150 mg, 300 mg, 450 mg, and 600 mg)

CK-4021586 administered orally

DRUG

Placebo to match CK-4021586

Placebo administered orally

Locations (24)

Eastern Shore Research Institute, LLC

Fairhope, Alabama, United States

University of Arizona Sarver Heart Center

Tucson, Arizona, United States

John L. McClellan Memorial Veterans Hospital

Little Rock, Arkansas, United States

BioSolutions Clinical Research Center

Imperial, California, United States

Profound Research LLC

Pasadena, California, United States

University of California, San Francisco - Heart and Vascular Center

San Francisco, California, United States

FOMAT - Comprehensive Cardiovascular Care

Santa Maria, California, United States

Blue Coast Research Center, LLC

Vista, California, United States

New Generation of Medical Research

Hialeah, Florida, United States

Cleveland Clinic Florida

Weston, Florida, United States

Methodist Medical Center of Illinois

Peoria, Illinois, United States

Louisiana Heart Center

Slidell, Louisiana, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

Mayo Clinic

Rochester, Minnesota, United States

Washington University Center for Advanced Medicine

St Louis, Missouri, United States

Morristown Medical Center

Morristown, New Jersey, United States

NYU Langone Health

New York, New York, United States

The Lindner Center for Research & Education at The Christ Hospital

Cincinnati, Ohio, United States

Oregon Health and Science University

Portland, Oregon, United States

University of Texas Southwestern Medical Center, Dallas

Dallas, Texas, United States

Center for Advanced Heart Failure

Houston, Texas, United States

DelRicht Research

Vienna, Virginia, United States

Swedish Heart & Vascular Institute, Advanced Cardiac Support Program

Seattle, Washington, United States

Froedtert Hospital - Center for Advanced Care

Milwaukee, Wisconsin, United States